SHMT2 and cancer: These results indicate that mitochondrial targeting significantly enhances the inhibitory effects of UTR2 RNA, likely by selectively inhibiting the mitochondrial SHMT2 pool, responsible for the Ser-to-Gly conversion necessary for the survival of cancer cells.